GENGWEN TIAN to Immunotherapy
This is a "connection" page, showing publications GENGWEN TIAN has written about Immunotherapy.
Connection Strength
0.143
-
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy. Blood. 2014 Oct 30; 124(18):2824-33.
Score: 0.074
-
Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells. Clin Immunol. 2013 Oct; 149(1):55-64.
Score: 0.069